Trial0
Sign inMap the options

Clinical trial · NCT06800469

Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer

Recruiting

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Request access helpRegistry record ↗

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

Pancreatic head cancer represents one of the most frequent malignancies with an incidence of about 13500 new cases each year. The primary objective of the study is to test whether there are bacterial species associated with increased risk of complications in patients with peri-ampullary neoplasia undergoing DCP.

Interventions

  • Microbiota analysis · DIAGNOSTIC_TEST

    Upon acquisition of informed consent, fecal, digiunal mucosa, biliary and pancreatic fluid samples will be collected for microbiota analysis

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* Age ≥18 years
* Diagnosis of resectable pancreatic adenocarcinoma with indication for "upfront" surgical treatment
* ASA (American Society of Anesthesiology) score \< 4
* Obtaining informed consent

Exclusion Criteria:

\- Pregnant or lactating women

Sites (1)

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, BO · Recruiting

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2025-01-30.